RxDoctor Payments Data

Maria Torres, MD

Family Medicine · Titusville, FLNPI 1104928167

Payments from drug & device makers

$223in general payments, 2019–2025

Across 7 payments — averaging $31.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$100
  • Exact Sciences$46
  • Biogen$24
  • Pfizer$21
  • Amneal Pharmaceuticals LLC$16
  • Alfasigma USA, Inc.$16

What the payments were for

  • Food & beverage$223100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca1$100
Exact Sciences2$46
Biogen1$24
Pfizer1$21
Amneal Pharmaceuticals LLC1$16
Alfasigma USA, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$223 in reported general payments places this provider in the 35th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$292,909
Medicare patients
448
Services billed
5,419

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide104$123,775
JardianceEmpagliflozin31$41,218
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$34,752
EliquisApixaban29$33,183
RybelsusSemaglutide19$29,534
ProliaDenosumab14$24,107
JanuviaSitagliptin Phosphate16$23,636
MounjaroTirzepatide26$22,895
XareltoRivaroxaban23$21,899
JanumetSitagliptin Phos/Metformin Hcl15$17,592
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog27$15,300
TrulicityDulaglutide15$15,072
Breo ElliptaFluticasone/Vilanterol12$9,557
SymbicortBudesonide/Formoterol Fumarate12$7,788
Levothyroxine Sodium533$5,609

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$21$33,18329 claims
AstraZenecaSymbicort$100$7,78812 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$16$5,609533 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Titusville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →